State Street Corp Immatics N.V. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Immatics N.V. stock. As of the latest transaction made, State Street Corp holds 225,202 shares of IMTX stock, worth $1.84 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

225,202

Previous 202,492 11.22%

Holding current value

$1.84 Million

Previous $2.35 Million 9.23%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$10.93 - $12.92 $248,220 - $293,413	22,710 Added 11.22%	225,202 $2.57 Million
Q2 2024 Aug 14, 2024	BUY	$9.78 - $13.49 $1.98 Million - $2.73 Million	202,492 New	202,492 $2.35 Million
Q4 2023 Feb 14, 2024	SELL	$7.36 - $10.89 $13,601 - $20,124	-1,848 Reduced 5.78%	30,100 $316,000
Q3 2023 Nov 14, 2023	SELL	$11.01 - $12.62 $8,752 - $10,032	-795 Reduced 2.43%	31,948 $369,000
Q2 2023 Aug 14, 2023	SELL	$5.92 - $12.72 $4,220 - $9,069	-713 Reduced 2.13%	32,743 $377,000
Q1 2023 May 15, 2023	BUY	$6.74 - $9.44 $225,493 - $315,824	33,456 New	33,456 $230,000
Q2 2022 Aug 15, 2022	SELL	$6.0 - $9.37 $569,388 - $889,194	-94,898 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$6.64 - $12.85 $22,449 - $43,445	3,381 Added 3.69%	94,898 $758,000
Q4 2021 Feb 14, 2022	BUY	$10.81 - $14.38 $677,559 - $901,324	62,679 Added 217.35%	91,517 $1.23 Million
Q3 2021 Nov 15, 2021	BUY	$11.58 - $15.46 $7,086 - $9,461	612 Added 2.17%	28,838 $375,000
Q2 2021 Aug 16, 2021	BUY	$10.43 - $12.81 $294,397 - $361,575	28,226 New	28,226 $328,000

Others Institutions Holding IMTX

# of Institutions

101

Shares Held

75.8M

Call Options Held

238K

Put Options Held

727K

View Full List

About Immatics N.V.

Ticker IMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,227,000
Market Cap $623M
Description
Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...

More about IMTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Immatics N.V. Transaction History